Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lina Jonsson

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Ebiomedicine|January 31, 2025
Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrumThuy-Dung Nguyen, Joeri J Meijsen, Robert Sigström, et al.
Nature Communications|August 29, 2018
MAP1B mutations cause intellectual disability and extensive white matter deficitG Bragi Walters, Omar Gustafsson, Gardar Sveinbjornsson, et al.
The Lancet. Psychiatry|April 13, 2025
Recommendations for defining treatment outcomes in major psychiatric disorders using real-world dataElise Koch, Sophie Smart, Guðmundur Einarsson, et al.
Translational Psychiatry|October 19, 2019
Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorderOlafur O Gudmundsson, G Bragi Walters, Andres Ingason, et al.
Current Biology : CB|October 9, 2020
Sequence Variants in TAAR5 and Other Loci Affect Human Odor Perception and NamingRosa S Gisladottir, Erna V Ivarsdottir, Agnar Helgason, et al.
Ebiomedicine|April 16, 2025
Genome-wide association meta-analyses of drug-resistant epilepsyCostin Leu, Andreja Avbersek, Remi Stevelink, et al.
Nature Immunology|September 7, 2023
Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targetsJing Hua Zhao, David Stacey, Niclas Eriksson, et al.
Nature Immunology|August 10, 2023
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targetsJing Hua Zhao, David Stacey, Niclas Eriksson, et al.
Nature Genetics|April 12, 2022
Exome sequencing in bipolar disorder identifies AKAP11 as a risk gene shared with schizophreniaDuncan S Palmer, Daniel P Howrigan, Sinéad B Chapman, et al.
Biological Psychiatry|June 2, 2025
New Genomics Discoveries Across the Bipolar Disorder Spectrum Implicate Neurobiological and Developmental PathwaysKevin S O'Connell, Rolf Adolfsson, Till F M Andlauer, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Ebiomedicine|January 31, 2025
Genetic insights into psychotic major depressive disorder: bridging the mood-psychotic disorder spectrumThuy-Dung Nguyen, Joeri J Meijsen, Robert Sigström, et al.
Nature Communications|August 29, 2018
MAP1B mutations cause intellectual disability and extensive white matter deficitG Bragi Walters, Omar Gustafsson, Gardar Sveinbjornsson, et al.
The Lancet. Psychiatry|April 13, 2025
Recommendations for defining treatment outcomes in major psychiatric disorders using real-world dataElise Koch, Sophie Smart, Guðmundur Einarsson, et al.
Translational Psychiatry|October 19, 2019
Attention-deficit hyperactivity disorder shares copy number variant risk with schizophrenia and autism spectrum disorderOlafur O Gudmundsson, G Bragi Walters, Andres Ingason, et al.
Current Biology : CB|October 9, 2020
Sequence Variants in TAAR5 and Other Loci Affect Human Odor Perception and NamingRosa S Gisladottir, Erna V Ivarsdottir, Agnar Helgason, et al.
Ebiomedicine|April 16, 2025
Genome-wide association meta-analyses of drug-resistant epilepsyCostin Leu, Andreja Avbersek, Remi Stevelink, et al.
Nature Immunology|September 7, 2023
Author Correction: Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targetsJing Hua Zhao, David Stacey, Niclas Eriksson, et al.
Nature Immunology|August 10, 2023
Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targetsJing Hua Zhao, David Stacey, Niclas Eriksson, et al.
Nature Genetics|April 12, 2022
Exome sequencing in bipolar disorder identifies AKAP11 as a risk gene shared with schizophreniaDuncan S Palmer, Daniel P Howrigan, Sinéad B Chapman, et al.
Biological Psychiatry|June 2, 2025
New Genomics Discoveries Across the Bipolar Disorder Spectrum Implicate Neurobiological and Developmental PathwaysKevin S O'Connell, Rolf Adolfsson, Till F M Andlauer, et al.
Pageof 6